These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon]. Laroche GP; Thériault G Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549 [TBL] [Abstract][Full Text] [Related]
30. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease. Sunderland GT; Belch JJ; Sturrock RD; Forbes CD; McKay AJ Clin Rheumatol; 1988 Mar; 7(1):46-9. PubMed ID: 3044673 [TBL] [Abstract][Full Text] [Related]
31. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes. Vayssairat M J Rheumatol; 1996 Nov; 23(11):1917-20. PubMed ID: 8923366 [TBL] [Abstract][Full Text] [Related]
32. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. Cooke ED; Pockley AG; Tucker AT; Kirby JD; Bolton AE Int Angiol; 1997 Dec; 16(4):250-4. PubMed ID: 9543222 [TBL] [Abstract][Full Text] [Related]
33. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial. Lukác J; Rovenský J; Tauchmannová H; Zitnan D Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837 [TBL] [Abstract][Full Text] [Related]
34. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. Corbin DO; Wood DA; Macintyre CC; Housley E Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704 [TBL] [Abstract][Full Text] [Related]
35. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects. Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997 [TBL] [Abstract][Full Text] [Related]
36. Treatment of Raynaud's phenomenon. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon. Walton A J Bodyw Mov Ther; 2008 Jul; 12(3):274-80. PubMed ID: 19083682 [TBL] [Abstract][Full Text] [Related]
39. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial. Wise RA; Malamet R; Wigley FM J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649 [TBL] [Abstract][Full Text] [Related]
40. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial. Muir AH; Robb R; McLaren M; Daly F; Belch JJ Vasc Med; 2002; 7(4):265-7. PubMed ID: 12710841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]